Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB303954

HVEM/TNFRSF14 Antibody (2742B), DyLight 405, Novus Biologicals™
SDP

Rabbit Monoclonal Antibody

Supplier:  Novus Biologicals FAB3563E

Catalog No. NB303954


Only null left
Add to Cart

Description

Description

HVEM/TNFRSF14 Monoclonal antibody specifically detects HVEM/TNFRSF14 in Human samples. It is validated for Flow Cytometry, Neutralization
Specifications

Specifications

HVEM/TNFRSF14
Monoclonal
DyLight 405
50mM Sodium Borate
Rabbit
Protein A or G purified from cell culture supernatant
RUO
Primary
Human
Purified
Flow Cytometry, Neutralization
2742B
Flow Cytometry, Neutralization
CD270 antigen, CD40-like protein, Herpes virus entry mediator A, Herpesvirus entry mediator A, HveA, HVEMTR2HVEAATAR, LIGHTR, tumor necrosis factor receptor superfamily member 14, tumor necrosis factor receptor superfamily, member 14 (herpesvirus entrymediator), Tumor necrosis factor receptor-like 2, tumor necrosis factor receptor-like gene2
Human embryonic kidney cell HEK293-derived human HVEM/TNFRSF14, Pro37-Val202, Accession # Q92956
0.1 mL
Apoptosis, B Cell Development and Differentiation Markers, Cancer, Immunology
8764
Store at 4C in the dark.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.